WO2012175602A3 - Elisa for calprotectin - Google Patents
Elisa for calprotectin Download PDFInfo
- Publication number
- WO2012175602A3 WO2012175602A3 PCT/EP2012/061948 EP2012061948W WO2012175602A3 WO 2012175602 A3 WO2012175602 A3 WO 2012175602A3 EP 2012061948 W EP2012061948 W EP 2012061948W WO 2012175602 A3 WO2012175602 A3 WO 2012175602A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- calprotectin
- elisa
- provides
- quantification
- monoclonal antibody
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4727—Calcium binding proteins, e.g. calmodulin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention provides an improved method for the immunological detection and quantification of calprotectin, based on a monoclonal antibody. The invention further provides a method for selecting antibodies that react adequately with calprotectin in stool extracts.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20110896 | 2011-06-21 | ||
NO20110896A NO336551B1 (en) | 2011-06-21 | 2011-06-21 | Improved ELISA for calprotectin in faecal or gastrointestinal tract test |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012175602A2 WO2012175602A2 (en) | 2012-12-27 |
WO2012175602A3 true WO2012175602A3 (en) | 2013-06-13 |
Family
ID=46331308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2012/061948 WO2012175602A2 (en) | 2011-06-21 | 2012-06-21 | Elisa for calprotectin |
Country Status (2)
Country | Link |
---|---|
NO (1) | NO336551B1 (en) |
WO (1) | WO2012175602A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013132347A2 (en) * | 2012-03-06 | 2013-09-12 | Calpro As | Improved elisa immunoassay for calprotectin |
EP3248015A1 (en) * | 2015-01-23 | 2017-11-29 | Westfälische Wilhelms-Universität Münster | Compounds and methods for the detection of calprotectin |
CA2998349A1 (en) | 2015-09-17 | 2017-03-23 | Amgen Inc. | Prediction of clinical response to il23-antagonists using il23 pathway biomarkers |
KR20180096633A (en) | 2015-12-22 | 2018-08-29 | 암젠 인크 | CCL20 as a predictor of clinical response to IL23-antagonists |
EP3487874A1 (en) | 2016-07-20 | 2019-05-29 | Westfälische Wilhelms-Universität Münster | Complex-specific standardization of immunological methods for the quantification of s100a12 |
CN110609143A (en) * | 2019-10-31 | 2019-12-24 | 苏州普瑞森基因科技有限公司 | Calprotectin heterodimer detection kit and application thereof |
CN114891103B (en) * | 2022-06-11 | 2023-07-07 | 巴迪泰(青岛)生物科技有限公司 | Calprotectin monoclonal antibody and kit |
CN117607461A (en) * | 2023-12-06 | 2024-02-27 | 陕西省动物研究所 | Detection method of S100A8 protein and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002088181A2 (en) * | 2001-04-30 | 2002-11-07 | Switch Biotech Ag | Mrp8/mrp14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound-healing disturbances |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0937259B1 (en) | 1996-11-01 | 2004-10-06 | Magne K. Fagerhol | Process for the extraction of proteins |
-
2011
- 2011-06-21 NO NO20110896A patent/NO336551B1/en not_active IP Right Cessation
-
2012
- 2012-06-21 WO PCT/EP2012/061948 patent/WO2012175602A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002088181A2 (en) * | 2001-04-30 | 2002-11-07 | Switch Biotech Ag | Mrp8/mrp14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound-healing disturbances |
Non-Patent Citations (2)
Title |
---|
LUEGERING N ET AL: "Immunohistochemical distribution and serum levels of the Ca2+-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease", DIGESTION, S. KARGER AG., BASEL, CH, vol. 56, no. 5, 1 January 1995 (1995-01-01), pages 406 - 414, XP009019238, ISSN: 0012-2823, DOI: 10.1159/000201267 * |
ROSETH A G ET AL: "ASSESSMENT OF THE NEUTROPHIL DOMINATING PROTEIN CALPROTECTIN IN FECES A METHODOLOGIC STUDY", SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, INFORMA HEALTHCARE, GB, vol. 27, no. 9, 1 January 1992 (1992-01-01), pages 793 - 798, XP009110340, ISSN: 0036-5521, DOI: 10.3109/00365529209011186 * |
Also Published As
Publication number | Publication date |
---|---|
NO20110896A1 (en) | 2012-12-24 |
NO336551B1 (en) | 2015-09-28 |
WO2012175602A2 (en) | 2012-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012175602A3 (en) | Elisa for calprotectin | |
WO2014165082A3 (en) | Antibodies and methods of detection | |
MX337535B (en) | Antibody, kit and method for determining amyloid peptides. | |
WO2014165771A3 (en) | Anti-il-4 antibodies and bispecific antibodies and uses thereof | |
IL222359A0 (en) | Monoclonal antibodies against her2 antigens, and uses therefor | |
EP2322562A4 (en) | Monoclonal antibody, and immunoassay using same | |
GB201108236D0 (en) | Method | |
NZ631098A (en) | Anti-hepcidin antibodies and uses thereof | |
EP3638320A4 (en) | Igf-1r monoclonal antibodies and uses thereof | |
WO2013092611A3 (en) | Method for the detection of free binding partner of a multispecific binder | |
EP2550147B8 (en) | Immunoassays, methods for carrying out immunoassays, immunoassay kits and method for manufacturing immunoassay kits | |
WO2013009521A3 (en) | Methods and compositions for treating asthma using anti-il-13 antibodies | |
BR112013013573A2 (en) | method for producing antibodies specific for an antigen of interest, isolated or recombinant b-cell, antibody population, and antibody | |
WO2013049704A3 (en) | Method and system of particle-phage epitope complex | |
WO2014143343A8 (en) | Hcv core lipid binding domain monoclonal antibodies | |
BR112012025082A2 (en) | new monoclonal antibodies and d-dimer immunoassay method | |
MX349661B (en) | Method for the detection of a binding partner of a multispecific binder. | |
SG11201402709WA (en) | Method and device for assaying an antigen present on erythrocytes or an antibody binding to an antigen present on erythrocytes | |
BR112012019475A8 (en) | use of an anti-cd44 monoclonal antibody, anti-cd44 monoclonal antibody, humanized anti-cd44 antibody and kit for detecting hnscc in a sample | |
WO2015006337A3 (en) | Compositions and methods for increasing protein half-life in a serum | |
WO2013115410A3 (en) | Anti-phospholipase d4 antibody | |
EP2308899A4 (en) | Antibody complex, antigen detection method, and method for production of antibody complex | |
EP3722311A4 (en) | Anti-human il6 monoclonal antibodies, preparation method therefor and use thereof | |
GB201119585D0 (en) | Assay | |
WO2011120015A3 (en) | Method and system of particle-coupled phage epitope |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12729114 Country of ref document: EP Kind code of ref document: A2 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12729114 Country of ref document: EP Kind code of ref document: A2 |